Headlines Covid-19 Specialties Trending Feeds Videos

FDA Approval Insights: Nivolumab/Cabozantinib in Advanced RCC

posted 21 hours

Mashup Score: 5

OncLive - In our exclusive interview, Toni K. Choueiri, MD, provides perspective on the FDA approval of nivolumab and cabozantinib in advanced renal cell...

Durvalumab, Osimertinib Envelop Adjuvant and Neoadjuvant NSCLC Treatment

posted 2 days

Mashup Score: 2

OncLive - The sustained overall survival benefit with durvalumab and significant disease-free survival benefit benefit with osimertinib in the adjuvant setting represent major advances in the...

Immunotherapy Finds a Role in Frontline Small Cell Lung Cancer and Mesothelioma

posted 2 days

Mashup Score: 2

OncLive - Checkpoint inhibitors have failed to improve progression-free survival and overall survival as second-line therapy and maintenance therapy in small cell lung cancer, but this...

  • Checkpoint inhibitors have failed to improve PFS and overall survival as second-line therapy and maintenance therapy in SCLC, but this class of agents continue to show encouraging activity worthy of a paradigm shift up front. @ColumbiaMed @gotoPER #lcsm https://t.co/d8m7SMfG1f

Novartis Signs In-Licensing Agreement With BeiGene to Expand Tislelizumab Trials Globally

posted 17 hours

Mashup Score: 1

OncLive - January 26, 2021 – Novartis has signed a strategic collaboration agreement to in-license the PD-1 inhibitor tislelizumab from BeiGene, Ltd, in various markets outside...

Immunotherapy Could Restore the Value of Neoadjuvant Therapy in Lung Cancer

posted 15 hours

Mashup Score: 1

OncLive - David Spigel, MD, discusses ongoing research with immunotherapy in early-stage lung...

Lung-Sparing Nodule Resection Gains Traction in Lung Cancer, But Needs Multidisciplinary Considerations

posted 7 hours

Mashup Score: 1

OncLive - Henning Gaissert, MD, discusses the importance of tailoring surgical resection strategies to individual patients with lung...

  • Although lung-sparing lung nodule resection in the form of lesser resection is available to some patients with lung cancer, it is critical to tailor surgical interventions based on pathologic assessment results. @MassGeneralNews #lcsm https://t.co/xbeETMila7

Avelumab Approved in Europe for Frontline Maintenance in Metastatic Urothelial Carcinoma

posted 2 days

Mashup Score: 1

OncLive - January 25, 2021 – The European Commission has approved avelumab for use as a frontline maintenance option in the treatment of adult patients with...

Toripalimab Granted FDA Fast Track Status for Mucosal Melanoma

posted 2 days

Mashup Score: 1

OncLive - January 25, 2021 – The FDA has granted toripalimab a fast track designation for use in the frontline treatment of patients with mucosal...

Frontline Pembrolizumab Approved in Europe for Metastatic MSI-H/dMMR CRC

posted 20 hours

Mashup Score: 1

OncLive - January 26, 2021 – The European Commission has approved single-agent pembrolizumab for use in the frontline treatment of patients with metastatic microsatellite instability–high or...

Lung-Sparing Nodule Resection Gains Traction in Lung Cancer, But Needs Multidisciplinary Considerations

posted 2 days

Mashup Score: 1

OncLive - Henning Gaissert, MD, discusses the importance of tailoring surgical resection strategies to individual patients with lung...

  • Although lung-sparing lung nodule resection in the form of lesser resection is available to some patients with lung cancer, it is critical to tailor surgical interventions based on pathologic assessment results. @MassGeneralNews #lcsm https://t.co/QiY6tTJqa7